SD Cystic Fibrosis Study

NCT00605761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: SB656933
DRUG: SB656933

Sponsor

GlaxoSmithKline